查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1678709

细胞治疗技术市场规模、份额、趋势分析报告：按产品类型、工作流程、细胞类型、最终用途、地区和细分市场进行预测，2025 年至 2030 年

Cell Therapy Technologies Market Size, Share & Trends Analysis Report By Product (Raw Materials, Instruments), By Workflow (Separation, Expansion), By Cell Type (T-cells, Stem Cells), By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

细胞治疗技术市场的成长和趋势

根据 Grand View Research, Inc. 的一份新报告，全球细胞治疗市场预计到 2030 年将达到 174.6 亿美元，2025 年至 2030 年的复合年增长率为 17.84%。

市场受到对先进疗法日益增长的需求的推动，特别是在癌症、自体免疫疾病和再生医学领域。自动化、生物製程创新、增加研发投入以及支援性法规正在推动成长。各公司正在扩大製造能力和伙伴关係，以提高效率、可扩展性和产品开发，预计将进一步推动对细胞治疗技术的需求。

COVID-19 疫情增加了研发投入、临床试验和对先进疗法的需求，加速了细胞治疗技术市场的发展。 COVID-19 疫情凸显了再生医学和免疫治疗领域对自动化、高效製造和可扩展生产的需求，从而刺激了创新和产业成长。这些因素正在推动市场的成长，预计在预测期内市场将呈指数级增长。

CAR-T、TCR-T 和干细胞疗法等先进细胞疗法的日益普及预计将进一步推动对细胞治疗技术的需求。基因编辑、自动化和生物加工方面的创新正在提高效率、可扩展性和生产品质。随着越来越多性化和再生疗法核准，对专用设备、成分和製造解决方案的需求将持续成长。预计这些因素将在预测期内推动市场成长。

细胞治疗技术的高成本可能会减缓未来几年的市场成长。原料昂贵、製造工序复杂、法规严格，导致生产成本高。由于企业需要专门的设备、技术纯熟劳工和先进的技术，这也会增加费用。有限的保险覆盖范围和定价挑战可能会进一步限制采用。透过更好的流程、自动化和扩大生产规模来降低成本可能是未来成长的关键。

细胞治疗技术市场报告重点

  • 按产品划分，消耗品部分在 2024 年占据了 42.70% 的最大市场占有率。这是因为它广泛用于培养、扩增和处理细胞。研究、临床测试和商业製造对试剂、生长因子和培养基的持续需求正在推动显着的成长。另一方面，预计预测期内软体将以最快的复合年增长率成长。
  • 根据工作流程，由于治疗开发和製造对自动化和高效细胞分离技术的需求不断增长，分离部分预计将引领市场并以最快的复合年增长率（2025-2030 年）成长。预计预测期内扩张部分将大幅成长。
  • 根据细胞类型，由于 CAR-T 和 TCR-T 疗法在癌症、自体免疫疾病和感染疾病中的应用越来越多，以及基因编辑和细胞增殖技术的进步，T 细胞部分预计将占据市场主导地位并以最快的复合年增长率（2025-2030 年）增长。预计预测期内干细胞部分将大幅成长。
  • 根据最终用途，生物製药和製药公司部门在 2024 年占据了市场主导地位，这归因于对细胞疗法研发的投资增加、对先进疗法的需求不断增长以及癌症、自体免疫疾病和再生疗法的商业性製造能力的扩大。另一方面，预计预测期内 CMO 和 CRO 将以最快的复合年增长率成长。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章 细胞治疗技术市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 细胞治疗技术市场分析工具
    • 产业分析 – 波特五力分析
    • PESTEL 分析
    • COVID-19影响分析

第四章 细胞治疗技术市场：产品评估及趋势分析

  • 细分仪表板
  • 全球细胞治疗技术市场产品趋势分析
  • 2018 年至 2030 年全球细胞治疗技术市场规模及趋势分析（依产品划分）
  • 原料
    • 培养基
    • 血清
    • 细胞培养补充剂
    • 抗体
    • 试剂和缓衝液
    • 其他的
  • 装置
    • 细胞治疗处理系统
    • 细胞培养系统
    • 细胞分选分离系统
    • 其他设备
    • 软体
    • 耗材及配件

第 5 章细胞治疗技术市场：按工作流程进行的估计和趋势分析

  • 细分仪表板
  • 全球细胞治疗技术市场工作流程变化分析
  • 2018 年至 2030 年全球细胞治疗技术市场规模与趋势分析（依工作流程）
  • 分离
  • 扩张
  • 血液成分分析
  • 灌装-精加工
  • 冷冻保存
  • 其他的

第六章细胞治疗技术市场：按细胞类型估计和趋势分析

  • 细分仪表板
  • 全球细胞治疗技术市场细胞类型变异分析
  • 2018 年至 2030 年全球细胞治疗技术市场规模及趋势分析（依细胞类型）
  • T 细胞
  • 干细胞
  • 其他细胞

第七章 细胞治疗技术市场：按最终用途的估计和趋势分析

  • 细分仪表板
  • 全球细胞治疗技术市场最终用途变化分析
  • 2018 年至 2030 年全球细胞治疗技术市场规模及趋势分析（依最终用途）
  • 生物製药和生物技术公司
  • CMO 和 CRO
  • 其他的

第 8 章 细胞治疗技术市场：区域估计与趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018-2030 年市场规模及预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争格局

  • 公司/竞争对手分类
  • 战略地图
  • 2024 年企业市场分析
  • 公司简介/上市公司
    • Danaher Corporation
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • Lonza Group
    • Sartorius AG
    • Promega
    • BD
    • Miltenyi BIoTec
    • CellPort Software
    • Shimadzu
Product Code: GVR-4-68040-516-0

Cell Therapy Technologies Market Growth & Trends:

The global cell therapy technologies market size is anticipated to reach USD 17.46 billion by 2030, registering a CAGR of 17.84% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by rising demand for advanced treatments, especially in cancer, autoimmune diseases, and regenerative medicine. Automation, bioprocessing innovations, increasing R&D investments, and supportive regulations fuel growth. Companies are expanding manufacturing capabilities and partnerships to improve efficiency, scalability, and product development, which is further anticipated to fuel the demand for cell therapy technologies.

The COVID-19 pandemic accelerated the cell therapy technologies market by increasing R&D investments, clinical trials, and demand for advanced therapies. It highlighted the need for automation, efficient manufacturing, and scalable production in regenerative medicine and immune-based treatments, driving innovation and industry growth. These factors have impelled the growth of the market and are anticipated to propel exponentially over the forecast period.

The growing adoption of advanced cell therapies, including CAR-T, TCR-T, and stem cell treatments, is expected to drive further demand for cell therapy technologies. Innovations in gene editing, automation, and bioprocessing are enhancing efficiency, scalability, and production quality. As more personalized and regenerative treatments gain approval, the need for specialized equipment, raw materials, and manufacturing solutions will continue to rise. These factors are thus projected to impel the market's growth over the forecast period.

The high cost of cell therapy technologies could slow market growth in the coming years. Expensive raw materials, complex manufacturing, and strict regulations make production costly. Companies also need specialized equipment, skilled workers, and advanced technology, adding to expenses. Limited insurance coverage and pricing challenges may further restrict adoption. Reducing costs through better processes, automation, and scaling up production will be key for future growth.

Cell Therapy Technologies Market Report Highlights:

  • Based on products, the consumables segment held the largest market share of 42.70% in 2024 due to their wide use in cell culture, expansion, and processing. The recurring demand for reagents, growth factors, and media in research, clinical trials, and commercial production has driven significant growth. On the other hand, software is expected to grow at the fastest CAGR over the forecast period
  • Based on workflow, the separation segment is expected to lead the market and grow at the fastest CAGR (2025-2030) due to increasing demand for automated, efficient cell isolation techniques in therapy development and manufacturing. The expansion segment is expected to grow significantly over the forecast period
  • Based on cell-type, the T-cells segment is expected to dominate the market and grow at the fastest CAGR (2025-2030) due to increasing adoption of CAR-T and TCR-T therapies for cancer, autoimmune diseases, and infectious diseases, along with advancements in gene editing and cell expansion technologies. The stem cells segment is expected to grow significantly over the forecast period.
  • Based on end use, the biopharmaceutical & pharmaceutical companies segment dominated the market in 2024 due to increasing investments in cell therapy R&D, growing demand for advanced treatments, and expanding commercial manufacturing capabilities for cancer, autoimmune, and regenerative therapies. On the other hand, CMOs & CROs are expected to grow at the fastest CAGR over the forecast period

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product
    • 1.2.2. Workflow
    • 1.2.3. Cell Type
    • 1.2.4. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Cell Therapy Technologies Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Advancements in Cell-Based Therapies
      • 3.2.1.2. Increased Funding and Investment
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High Costs and Manufacturing Challenges
  • 3.3. Cell Therapy Technologies Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Cell Therapy Technologies Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Cell Therapy Technologies Market Product Movement Analysis
  • 4.3. Global Cell Therapy Technologies Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Raw Materials
    • 4.4.1. Raw materials market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Media
      • 4.4.2.1. Media market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Sera
      • 4.4.3.1. Sera market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Cell Culture Supplements
      • 4.4.4.1. Cell Culture Supplements market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5. Antibodies
      • 4.4.5.1. Antibodies market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.6. Reagents & Buffers
      • 4.4.6.1. Reagents & buffers market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.7. Others
      • 4.4.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Instruments
    • 4.5.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Cell Therapy Processing Systems
      • 4.5.2.1. Cell therapy processing systems market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Cell Culture Systems
      • 4.5.3.1. Cell culture systems market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.4. Cell Sorting & Separation Systems
      • 4.5.4.1. Cell sorting & separation systems market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.5. Other Instruments
      • 4.5.5.1. Other instruments market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.6. Software
      • 4.5.6.1. Software market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.7. Consumables & Accessories
      • 4.5.7.1. Consumables & accessories market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Cell Therapy Technologies Market: Workflow Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Cell Therapy Technologies Market Dosage Workflow Movement Analysis
  • 5.3. Global Cell Therapy Technologies Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
  • 5.4. Separation
    • 5.4.1. Separation market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Expansion
    • 5.5.1. Expansion market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Apheresis
    • 5.6.1. Apheresis market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Fill- Finish
    • 5.7.1. Fill- finish market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Cryopreservation
    • 5.8.1. Cryopreservation market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Cell Therapy Technologies Market: Cell Type Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Cell Therapy Technologies Market Cell Type Movement Analysis
  • 6.3. Global Cell Therapy Technologies Market Size & Trend Analysis, by Cell Type, 2018 to 2030 (USD Million)
  • 6.4. T-cells
    • 6.4.1. T-cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Stem Cells
    • 6.5.1. Stem cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Other Cells
    • 6.6.1. Other cells market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Cell Therapy Technologies Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Cell Therapy Technologies Market End Use Movement Analysis
  • 7.3. Global Cell Therapy Technologies Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Biopharmaceutical & Biotechnology Companies
    • 7.4.1. Biopharmaceutical & biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. CMOs & CROs
    • 7.5.1. CMOs & CROs market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Cell Therapy Technologies Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 8.4. North America
    • 8.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Regulatory framework
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.7. Norway
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Regulatory framework
      • 8.5.7.3. Competitive scenario
      • 8.5.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.8. Sweden
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Regulatory framework
      • 8.5.8.3. Competitive scenario
      • 8.5.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.9. Denmark
      • 8.5.9.1. Key country dynamics
      • 8.5.9.2. Regulatory framework
      • 8.5.9.3. Competitive scenario
      • 8.5.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Regulatory framework
      • 8.6.7.3. Competitive scenario
      • 8.6.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Regulatory framework
      • 8.8.3.3. Competitive scenario
      • 8.8.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. Regulatory framework
      • 8.8.4.3. Competitive scenario
      • 8.8.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key country dynamics
      • 8.8.5.2. Regulatory framework
      • 8.8.5.3. Competitive scenario
      • 8.8.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2024
  • 9.4. Company Profiles/Listing
    • 9.4.1. Danaher Corporation
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Merck KGaA
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Thermo Fisher Scientific Inc.
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Lonza Group
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Sartorius AG
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Promega
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. BD
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Miltenyi Biotec
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. CellPort Software
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Shimadzu
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global cell therapy technologies market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 5 Global cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 6 Global cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 7 North America cell therapy technologies market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 9 North America cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 10 North America cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 11 North America cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 12 U.S. cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 13 U.S. cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 14 U.S. cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 15 U.S. cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Canada cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 17 Canada cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 18 Canada cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 19 Canada cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Mexico cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 21 Mexico cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 22 Mexico cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 23 Mexico cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Europe cell therapy technologies market, by country, 2018 - 2030 (USD Million)
  • Table 25 Europe cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 26 Europe cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 27 Europe cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 28 Europe cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Germany cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 30 Germany cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 31 Germany cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 32 Germany cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 33 UK cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 34 UK cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 35 UK cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 36 UK cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 37 France cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 38 France cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 39 France cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 40 France cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Italy cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 42 Italy cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 43 Italy cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 44 Italy cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Spain cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 46 Spain cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 47 Spain cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 48 Spain cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 49 Denmark cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 50 Denmark cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 51 Denmark cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 52 Denmark cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Sweden cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 54 Sweden cell therapy technologies market, by workflow, 2018 - 2030 (USD Million
  • Table 55 Sweden cell therapy technologies market, by cell type, 2018 - 2030 (USD Million
  • Table 56 Sweden cell therapy technologies market, by end use, 2018 - 2030 (USD Million
  • Table 57 Norway cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 58 Norway cell therapy technologies market, by workflow, 2018 - 2030 (USD Million
  • Table 59 Norway cell therapy technologies market, by cell type, 2018 - 2030 (USD Million
  • Table 60 Norway cell therapy technologies market, by end use, 2018 - 2030 (USD Million
  • Table 61 Asia Pacific cell therapy technologies market, by country, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific cell therapy technologies market, by workflow, 2018 - 2030 (USD Million
  • Table 64 Asia Pacific cell therapy technologies market, by cell type, 2018 - 2030 (USD Million
  • Table 65 Asia Pacific cell therapy technologies market, by end use, 2018 - 2030 (USD Million
  • Table 66 China cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 67 China cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 68 China cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 69 China cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 70 Japan cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 71 Japan cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 72 Japan cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 73 Japan cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 74 India cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 75 India cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 76 India cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 77 India cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 78 South Korea cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 79 South Korea cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 80 South Korea cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 81 South Korea cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 82 Australia cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 83 Australia cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 84 Australia cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 85 Australia cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Thailand cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 87 Thailand cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 88 Thailand cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 89 Thailand cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 90 Latin America cell therapy technologies market, by country, 2018 - 2030 (USD Million)
  • Table 91 Latin America cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 92 Latin America cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 93 Latin America cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 94 Latin America cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 95 Brazil cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 96 Brazil cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 97 Brazil cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 98 Brazil cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 99 Argentina cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 100 Argentina cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 101 Argentina cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 102 Argentina cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 103 MEA cell therapy technologies market, by country, 2018 - 2030 (USD Million)
  • Table 104 MEA cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 105 MEA cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 106 MEA cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 107 MEA cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 108 South Africa cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 109 South Africa cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 110 South Africa cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 111 South Africa cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 116 UAE cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 117 UAE cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 118 UAE cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 119 UAE cell therapy technologies market, by end use, 2018 - 2030 (USD Million)
  • Table 120 Kuwait cell therapy technologies market, by product, 2018 - 2030 (USD Million)
  • Table 121 Kuwait cell therapy technologies market, by workflow, 2018 - 2030 (USD Million)
  • Table 122 Kuwait cell therapy technologies market, by cell type, 2018 - 2030 (USD Million)
  • Table 123 Kuwait cell therapy technologies market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Cell therapy technologies market: Market outlook
  • Fig. 5 Cell therapy technologies market: Segment outlook
  • Fig. 6 Cell therapy technologies market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Cell therapy technologies market driver impact
  • Fig. 9 Cell therapy technologies market restraint impact
  • Fig. 10 Cell therapy technologies market: Product outlook and key takeaways
  • Fig. 11 Cell therapy technologies market: Product movement analysis
  • Fig. 12 Raw materials market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 13 Media market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Sera market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Cell culture supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Antibodies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Reagents & buffers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Cell therapy processing systems market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Cell culture systems market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Cell sorting & separation systems market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Other instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Software market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Consumables & accessories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Cell therapy technologies market: Workflow outlook and key takeaways
  • Fig. 27 Cell therapy technologies market: Workflow movement analysis
  • Fig. 28 Separation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Expansion market estimates and forecast, 2018 - 2030 (USD Million
  • Fig. 30 Apheresis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Fill- finish market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Cryopreservation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Cell therapy technologies market: Cell type outlook and key takeaways
  • Fig. 35 Cell therapy technologies market: Cell type movement analysis
  • Fig. 36 T-cells market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Stem cells market estimates and forecast, 2018 - 2030 (USD Million
  • Fig. 38 Other cells market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Cell therapy technologies market: End use outlook and key takeaways
  • Fig. 40 Cell therapy technologies market: End use movement analysis
  • Fig. 41 Biopharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 CMOs & CROs market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 43 Others market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 44 Global cell therapy technologies market: Regional outlook and key takeaways
  • Fig. 45 Global cell therapy technologies market: Regional movement analysis
  • Fig. 46 North America cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 U.S. cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Canada cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Mexico cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Europe cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 UK cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Germany cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 France cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Italy cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Spain cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Denmark cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Sweden cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Norway cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Asia Pacific cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 China cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Japan cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 India cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Thailand cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 South Korea cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Australia cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Latin America cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Brazil cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Argentina cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Middle East and Africa cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 South Africa cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Saudi Arabia cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 UAE cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Kuwait cell therapy technologies market estimates and forecasts, 2018 - 2030 (USD Million)